» Authors » Sanket Shah

Sanket Shah

Explore the profile of Sanket Shah including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 832
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhawale P, Shah S, Sharma K, Sikriwal D, Kumar V, Bhagawati A, et al.
Hum Vaccin Immunother . 2025 Feb; 21(1):2461844. PMID: 39999432
serotypes responsible for pneumococcal disease differ with respect to disease severity, invasiveness, antimicrobial susceptibility, geographies, immunization history, age groups, and with time. Although PCVs have blunted the pneumococcal disease burden,...
2.
Shah M, Shah K, Dave H, Khadela A, Desai C, Shah S, et al.
J Oncol Pharm Pract . 2025 Feb; :10781552251320349. PMID: 39962869
Background: Worldwide, lung cancer stands as a leading cause of mortality, with EGFR-mutated metastatic non-small cell lung cancer (NSCLC) accounting for a large percentage of cases in the Indian population....
3.
Bulusu S, Bavikatte A, Shah S, Murthy S, Kommoju V, Mariaselvam C, et al.
Immunology . 2025 Jan; 174(4):470-480. PMID: 39875315
Mechanisms contributing to non-response to treatment in lupus nephritis (LN) are unclear. We characterised the transcriptome of paired peripheral blood mononuclear cells (PBMCs) and renal tissues in LN before and...
4.
Lindsay S, Tumolva O, Khamiakova T, Coppenolle H, Kovarik M, Shah S, et al.
Pharmaceutics . 2024 Sep; 16(9). PMID: 39339196
Microfluidic liposome production presents a streamlined pathway for expediting the translation of liposomal formulations from the laboratory setting to clinical applications. Using this production method, resultant liposome characteristics can be...
5.
Lonare A, Raychaudhuri K, Shah S, Madhu G, Sachdeva A, Basu S, et al.
Int J Cancer . 2024 Sep; 156(3):623-637. PMID: 39239852
14-3-3σ functions as an oncogene in colorectal cancer and is associated with therapy resistance. However, the mechanisms underlying these observations are not clear. The results in this report demonstrate that...
6.
Bulusu S, Mariaselvam C, Shah S, Kommoju V, Kavadichanda C, Harichandrakumar K, et al.
Lupus . 2024 Jul; 33(10):1069-1081. PMID: 39033304
Objectives: To assess the longitudinal effect of cyclophosphamide (CYC) treatment on type-I interferon (IFN) signature in proliferative lupus nephritis (LN) and its role in predicting treatment response. Methods: Fifty-four biopsy...
7.
Holton C, Shah S, Miller J
ASAIO J . 2024 Jun; 70(11):994-1000. PMID: 38896850
The development of new right ventricular (RV) dysfunction after cannulation to venovenous (VV) extracorporeal membrane oxygenation (ECMO) and its association with worse outcomes is increasingly recognized in adult patients, however,...
8.
Katawale S, Tank S, Dhaygude H, Holm R, Shah S, Shinde U, et al.
Int J Pharm . 2024 Apr; 657:124147. PMID: 38657715
The present study investigated the feasibility of fabricating self-assembled liposomes, LeciPlex®, a phospholipid-based vesicular nanocarrier using cationic, anionic, and nonionic stabilizers. The phospholipid investigated was soy phosphatidylcholine and the nano-precipitation...
9.
Qureshi S, Voppuru S, Smriti V, Baheti A, Shah S, Chinnaswamy G, et al.
J Pediatr Surg . 2024 Mar; 59(8):1556-1563. PMID: 38521742
Background: Malignant ovarian germ cell tumors (MOGCT) are rare in children. Surgery with or without chemotherapy is the primary treatment approach. This study aimed to analyze the impact of primary...
10.
Goyal A, Kiaffas M, Swanson T, Kathol M, Shah S, Madan N
J Cardiovasc Dev Dis . 2024 Feb; 11(2). PMID: 38392269
Obtaining a three-vessel (3V) and three-vessel and trachea (3VT) view from the fetal upper mediastinum is now considered to be part of standard imaging protocol for routine obstetric cardiac screening...